# US 2024/0002895 A1 · Methods and compositions for melanin synthesis

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2024/0002895 A1
- Document ID: US20240002895A1
- Status: Published application
- Kind: A1
- Application number: 18/209,263
- Filed: 2023-06-13
- Published: 2024-01-04
- Earliest claimed: 2021-01-07
- Assignees: Ramot at Tel-Aviv University Ltd.
- Applicants: Ramot At Tel Aviv University Ltd.
- Inventors: Avigail-Elah BARUCH LESHEM; Ayala LAMPEL; Tlalit MASSARANO
- Web page: https://patentgrep.com/patent/US20240002895A1

## CPC

- A61K 31/404: Indoles, e.g. pindolol
- C12P 21/02: having a known sequence of two or more amino acids, e.g. glutathione
- A61K 8/0204: {Specific forms not provided for by any of groups A61K8/0208 - A61K8/14}
- A61K 8/44: Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
- A61K 8/66: Enzymes
- A61K 8/73: Polysaccharides
- A61K 8/84: obtained by reactions otherwise than those involving only carbon-carbon unsaturated bonds
- A61K 8/85: Polyesters
- A61K 31/198: Alpha-amino acids, e.g. alanine or edetic acid [EDTA] (betaine A61K31/205; proline A61K31/401; tryptophan A61K31/405; histidine A61K31/4172; peptides not degraded to individual amino acids A61K38/00)
- A61Q 5/10: Preparations for permanently dyeing the hair
- A61Q 19/04: for chemically tanning the skin (topical sun or radiation screening or tanning preparations A61Q17/04)
- A61K 2800/412: Microsized, i.e. having sizes between 0.1 and 100 microns
- A61K 2800/81: Preparation or application process involves irradiation
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- C12P: FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE {(brewing of beer C12C; producing vinegar C12J; producing specific peptides or proteins C07K; producing enzymes C12N9/00; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; measuring or testing processes involving enzymes or microorganisms C12Q; measuring or testing processes involving nucleic acid amplification reactions C12Q1/6844; fermentation processes to form a food composition, A21 or A23; compounds in general, see the relevant compound class, e.g. C01, C07)}
- A61Q: SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS

## Abstract

The invention relates to a composition comprising a polymer-based droplet, wherein the polymer-based droplet comprises one or more of melanin, a tyrosine substrate with a cleavable protecting group on the side chain, tyrosine, tyrosinase and any combination thereof. The composition further relates to a method of synthesizing melanin comprising the steps of: obtaining a polymer-based droplet containing a tyrosine substrate with a cleavable protecting group on the side chain (protected tyrosine) or a polymer-based droplet containing tyrosine (unprotected); wherein the tyrosine is oxidized by tyrosinase and polymerizes so as to obtain melanin.

## Claims

### Claim at position 1

-23. (canceled)

### Claim 24

A composition comprising a polymer-based droplet, wherein the polymer-based droplet comprises: (i) a tyrosine substrate with a cleavable protecting group on a side chain (protected tyrosine) or an unprotected tyrosine, and a tyrosinase; and/or (ii) melanin.

### Claim 25 (depends on 24)

The composition of claim 24, wherein the cleavable protecting group on a side chain of the tyrosine is photocleavable or chemically cleavable.

### Claim 26 (depends on 24)

The composition of claim 24, wherein the protected tyrosine is ortho-nitrobenzyl tyrosine (ONB-Y].

### Claim 27 (depends on 24)

The composition of claim 24, wherein the polymer-based droplet is a droplet of an aqueous two phase system (ATPS).

### Claim 28 (depends on 24)

The composition of claim 24, wherein the polymer of the polymer-based droplet comprises dextran, PEG, polyelectrolytes with opposite charges i.e. poly-lysine or poly-arginine with poly glutamic acid or poly-aspartic acid, or any combination thereof.

### Claim 29 (depends on 28)

The composition of claim 28, wherein the polymer is PEG and dextran and the amount of the PEG and dextran before phase separation is from 5-10 w/w % PEG and 10-w/w % dextran.

### Claim 30 (depends on 24)

The composition of claim 24, wherein the size of the droplet is between 100 nm to 200 μm.

### Claim 31 (depends on 24)

The composition of claim 24, wherein the droplet is a dextran rich droplet of a PEG/dextran ATPS.

### Claim 32

A method of synthesizing melanin comprising the steps of:
obtaining a polymer-based droplet containing a tyrosine substrate with a cleavable protecting group on a side chain (protected tyrosine) or a polymer-based droplet containing unprotected tyrosine; and
adding tyrosinase,
wherein if protected tyrosine is used, the method further comprises a step of cleaving the cleavable protecting group on the side chain of the protected tyrosine so as to obtain unprotected tyrosine;
and the unprotected tyrosine is oxidized by the tyrosinase and polymerizes so as to obtain melanin.

### Claim 33 (depends on 32)

The method of claim 32, wherein the protected tyrosine is ortho-nitrobenzyl tyrosine (ONB-Y).

### Claim 34 (depends on 32)

The method of claim 32, wherein the cleaving is by irradiation.

### Claim 35 (depends on 32)

The method of claim 32, wherein the irradiation is by UV irradiation.

### Claim 36 (depends on 32)

The method of claim 32, wherein the polymer is dextran, PEG, poly-lysine, and/or poly glutamic acid.

### Claim 37 (depends on 32)

The method of claim 32, wherein the polymer-based droplet is made by:
obtaining a solution of tyrosine substrate with cleavable protecting group on a side chain (protected tyrosine), or a solution of unprotected tyrosine;
obtaining a phase separation composition comprising at least two polymers or at least one polymer and a salt; and
separating.

### Claim 38 (depends on 32)

The method of claim 32, wherein the polymer-based droplet is made by:
obtaining a solution of tyrosine substrate with cleavable protecting group on the side chain (protected tyrosine), or a solution of unprotected tyrosine;
obtaining a PEG and dextran aqueous two-phase system (ATPS); and
separating.

### Claim 39 (depends on 32)

The method of claim 32, wherein the melanin synthesis is a spatially-controlled synthesis.

### Claim 40 (depends on 32)

The method of claim 32, wherein the droplet is a dextran rich droplet of PEG/dextran ATPS.

### Claim 41 (depends on 32)

The method of claim 32, wherein the tyrosinase catalyses oxidation of the tyrosine into 3, 4-dihydroxyphenylalanine (DOPA), then to dopaquinone, followed by cyclization to cycloDOPA and polymerization and stacking of 5,6-dihydroxyindole (DHI) and 5,6-dihydroxyindole-2-carboxylic acid (DHICA) lead to the formation of eumelanin.

### Claim 42 (depends on 24)

The composition of claim 24, further comprising an acceptable carrier.

### Claim 43 (depends on 42)

The composition of claim 42, wherein the composition is a dermal composition or a cosmetic composition and comprises a dermally or cosmetically acceptable carrier.
